Login to Your Account



Arpida Raises CHF51.3M, Plans To Move Iclaprim Into Phase III

By Cormac Sheridan


Wednesday, May 12, 2004
Arpida Ltd. raised CHF51.3 million (US$39.4 million) in a Series C funding round, bringing its total funding to date to CHF105 million. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription